Erratum
for
Baselga and Arteaga, J Clin Oncol 23 (11) 2445-2459.
Journal of Clinical Oncology, Vol 23, No 25 (September 1), 2005: pp. 6281
© 2005 American Society of Clinical Oncology.
DOI: 10.1200/JCO.2005.07.903
ERRATUM
The April 10, 2005, Overview by Baselga et al titled, "Critical Update and Emerging Trends in Epidermal Growth Factor Receptor Targeting in Cancer" (J Clin Oncol 23:2445-2459, 2005) contained an error.
On page 2446, in the third paragraph of the Monoclonal Antibodies Directed at the ERBB (HER) Family section, cetuximab is referred to as a chimeric immunoglobulin G2 (IgG2) MAb, whereas it is actually a chimeric immunoglobulin G1 (IgG1) MAb.

CiteULike Complore Connotea Del.icio.us Digg Facebook Reddit Technorati Twitter What's this?
|